<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="a group of chronic autoinflammatory diseases including Crohn’s disease and" exact="ulcerative colitis." post="Although the molecular mechanisms governing the pathogenesis of gastrointestinal"/>
 <result pre="intestinal microbiome was clearly primarily studied from the view of" exact="gastrointestinal disease." post="Inflammatory bowel diseases (IBDs) are a group of chronic"/>
 <result pre="diseases (IBDs) are a group of chronic autoinflammatory diseases including" exact="ulcerative colitis" post="(UC) and Crohn’s disease (CD). They are characterized by"/>
 <result pre="(IBDs) are a group of chronic autoinflammatory diseases including ulcerative" exact="colitis" post="(UC) and Crohn’s disease (CD). They are characterized by"/>
 <result pre="it is associated with many even seemingly unrelated diseases including" exact="liver disease" post="[11], neurobehavioral dysfunction in non-alcoholic steatosis [12], lung cancer"/>
 <result pre="including liver disease [11], neurobehavioral dysfunction in non-alcoholic steatosis [12]," exact="lung cancer" post="[13], or obstructive sleep apnea [14]. Furthermore, dysbiosis may"/>
 <result pre="liver disease [11], neurobehavioral dysfunction in non-alcoholic steatosis [12], lung" exact="cancer" post="[13], or obstructive sleep apnea [14]. Furthermore, dysbiosis may"/>
 <result pre="neurobehavioral dysfunction in non-alcoholic steatosis [12], lung cancer [13], or" exact="obstructive sleep apnea" post="[14]. Furthermore, dysbiosis may provoke the development or exacerbate"/>
 <result pre="dysfunction in non-alcoholic steatosis [12], lung cancer [13], or obstructive" exact="sleep apnea" post="[14]. Furthermore, dysbiosis may provoke the development or exacerbate"/>
 <result pre="development or exacerbate the course of inflammatory diseases such as" exact="rheumatoid arthritis" post="[15], systemic lupus erythematosus [16], or IBD [17]. The"/>
 <result pre="or exacerbate the course of inflammatory diseases such as rheumatoid" exact="arthritis" post="[15], systemic lupus erythematosus [16], or IBD [17]. The"/>
 <result pre="the course of inflammatory diseases such as rheumatoid arthritis [15]," exact="systemic lupus erythematosus" post="[16], or IBD [17]. The term &quot;dysbiosis�? usually encompasses"/>
 <result pre="course of inflammatory diseases such as rheumatoid arthritis [15], systemic" exact="lupus erythematosus" post="[16], or IBD [17]. The term &quot;dysbiosis�? usually encompasses"/>
 <result pre="these results were supported by a T-cell transfer model of" exact="colitis" post="in mice. In animals treated with T cells, reads"/>
 <result pre="carrying antibacterial resistance genes were detected in the sputum from" exact="cystic fibrosis" post="patients [60]. Conversely, another study analyzed the abundance of"/>
 <result pre="[63]. Therefore, phage SopEPhi indirectly contributes to the development of" exact="colitis" post="in streptomycin-pretreated mice [64]. Some proteins are even able"/>
 <result pre="FMT is effective in multiple gastrointestinal diseases such as CDI," exact="irritable bowel syndrome" post="(IBS), IBD, and CRC [67,68]. For instance, in the"/>
 <result pre="may, in turn, lead to other problems such as antibiotic-associated" exact="diarrhea" post="and C. difficile infection [76]. Conversely, phages do not"/>
 <result pre="even helpful in alleviating the symptoms of dextran sodium sulfate-induced" exact="colitis" post="in mice colonized with E. coli LF82. Strikingly, this"/>
 <result pre="the destruction of harmful bacterial strains and the alleviation of" exact="gastrointestinal disease," post="including IBD, must be determined. In addition to the"/>
 <result pre="in IBDJ. Crohns Colitis20171190592010.1093/ecco-jcc/jjx002.03828039310 11.ZengY.ChenS.FuY.WuW.ChenT.ChenJ.YangB.OuQ.Gut microbiota dysbiosis in patients with" exact="hepatitis" post="B virus-induced chronic liver disease covering chronic hepatitis, liver"/>
 <result pre="11.ZengY.ChenS.FuY.WuW.ChenT.ChenJ.YangB.OuQ.Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic" exact="liver disease" post="covering chronic hepatitis, liver cirrhosis and hepatocellular carcinomaJ. Viral"/>
 <result pre="hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver" exact="cirrhosis" post="and hepatocellular carcinomaJ. Viral Hepat.20202714315510.1111/jvh.1321631600845 12.HigarzaS.G.ArboleyaS.GueimondeM.Gomez-LazaroE.AriasJ.L.AriasN.Neurobehavioral dysfunction in non-alcoholic"/>
 <result pre="Alterations in the Enteric Virome in Inflammatory Bowel DiseaseCell201516044746010.1016/j.cell.2015.01.00225619688 30.DuerkopB.A.KleinerM.Paez-EspinoD.ZhuW.BushnellB.HassellB.WinterS.E.KyrpidesN.C.HooperL.V.Murine" exact="colitis" post="reveals a disease-associated bacteriophage communityNat. Microbiol.201831023103110.1038/s41564-018-0210-y30038310 31.FernandesM.A.VerstraeteS.G.PhanT.G.DengX.StekolE.LaMereB.LynchS.V.HeymanM.B.DelwartE.Enteric Virome and"/>
 <result pre="new therapy: From Clostridioides difficile infection to inflammatory bowel disease," exact="irritable bowel syndrome," post="and colon cancerCurr. Opin. Pharmacol.201949435110.1016/j.coph.2019.04.01731173991 68.NowakA.HedenstiernaM.UrsingJ.LidmanC.NowakP.Efficacy of Routine Fecal"/>
 <result pre="live and dead Salmonella-based vector strain on the course of" exact="colitis" post="in miceLett. Appl. Microbiol.20166334034610.1111/lam.1263227501439 75.LiptakR.GromovaB.MaronekM.GardlikR.Reverse phenotype transfer via fecal"/>
 <result pre="and genetically-modified phagesWorld J. Microbiol. Biotechnol.2016326710.1007/s11274-016-2009-426931607 81.ChassaingB.KorenO.CarvalhoF.A.LeyR.E.GewirtzA.T.AIEC pathobiont instigates chronic" exact="colitis" post="in susceptible hosts by altering microbiota compositionGut2014631069108010.1136/gutjnl-2013-30490923896971 82.BretinA.LucasC.LarabiA.DalmassoG.BillardE.BarnichN.BonnetR.NguyenH.T.T.AIEC infection"/>
</results>
